• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Finance
  • Payers
  • Regulatory
  • Special Reports
  • Podcasts
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Sanofi

Payers

California sues major PBMs, drugmakers over insulin prices

California has filed suit against a slew of major drugmakers and PBMs, alleging that they acted unlawfully to drive up the cost of insulin.
Paige Minemyer Jan 13, 2023 3:15pm

Optum, Sanofi team to offer low-cost insulin to uninsured

Aug 2, 2022 7:10am

Merck sues HHS to avoid fine over 340B restrictions

Jul 12, 2022 3:20pm

24 states support feds in 340B drugmaker lawsuit

May 17, 2022 7:50am

HRSA calls for Boehringer Ingelheim to be fined for 340B moves

Mar 31, 2022 7:10am

J&J to cut off 340B discounts to pharmacies starting in May

Mar 22, 2022 3:10pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy